| Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu–Natal, South Africa KI Barnes, DN Durrheim, F Little, A Jackson, U Mehta, E Allen, SS Dlamini, ... PLoS medicine 2 (11), e330, 2005 | 377 | 2005 |
| Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study U Mehta, DN Durrheim, M Blockman, T Kredo, R Gounden, KI Barnes British journal of clinical pharmacology 65 (3), 396-406, 2008 | 179 | 2008 |
| Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross‐sectional survey JP Mouton, U Mehta, AG Parrish, DPK Wilson, A Stewart, CW Njuguna, ... British journal of clinical pharmacology 80 (4), 818-826, 2015 | 127 | 2015 |
| Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: a randomised trial (DolPHIN-1 study) C Waitt, C Orrell, S Walimbwa, Y Singh, K Kintu, B Simmons, ... PLoS medicine 16 (9), e1002895, 2019 | 118 | 2019 |
| Adverse drug reactions causing admission to medical wards: a cross-sectional survey at 4 hospitals in South Africa JP Mouton, C Njuguna, N Kramer, A Stewart, U Mehta, M Blockman, ... Medicine 95 (19), e3437, 2016 | 110 | 2016 |
| Developing a national system for dealing with adverse events following immunization U Mehta, JB Milstien, P Duclos, PI Folb Bulletin of the World Health Organization 78 (2), 170-177, 2000 | 101 | 2000 |
| Is it safe to switch between efavirenz and nevirapine in the event of toxicity? U Mehta, G Maartens The Lancet Infectious Diseases 7 (11), 733-738, 2007 | 62 | 2007 |
| 72 weeks post-partum follow-up of dolutegravir versus efavirenz initiated in late pregnancy (DolPHIN-2): an open-label, randomised controlled study TR Malaba, I Nakatudde, K Kintu, A Colbers, T Chen, H Reynolds, L Read, ... The Lancet HIV 9 (8), e534-e543, 2022 | 55 | 2022 |
| Malaria deaths as sentinel events to monitor healthcare delivery and antimalarial drug safety U Mehta, DN Durrheim, L Blumberg, S Donohue, F Hansford, A Mabuza, ... Tropical Medicine & International Health 12 (5), 617-628, 2007 | 54 | 2007 |
| Noma (cancrum oris): A scoping literature review of a neglected disease (1843 to 2021) E Farley, U Mehta, ML Srour, A Lenglet PLoS neglected tropical diseases 15 (12), e0009844, 2021 | 52 | 2021 |
| Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis M Saito, R McGready, H Tinto, T Rouamba, D Mosha, S Rulisa, S Kariuki, ... The Lancet 401 (10371), 118-130, 2023 | 49 | 2023 |
| Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings U Mehta, C Clerk, E Allen, M Yore, E Sevene, J Singlovic, M Petzold, ... BMC pregnancy and childbirth 12 (1), 89, 2012 | 46 | 2012 |
| Pharmacovigilance: a public health priority for South Africa U Mehta, E Kalk, A Boulle, P Nkambule, J Gouws, H Rees, K Cohen South African health review 2017, 125, 2017 | 44 | 2017 |
| Spontaneous adverse drug reaction reporting in rural districts of Mozambique E Sevene, A Mariano, U Mehta, M Machai, A Dodoo, D Vilardell, S Patel, ... Drug safety 31 (10), 867-876, 2008 | 44 | 2008 |
| Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the … JP Mouton, U Mehta, DP Rossiter, G Maartens, K Cohen PloS one 12 (2), e0172830, 2017 | 43 | 2017 |
| Clinical practice Strengthening pharmacovigilance in South Africa U Mehta, M Blockman, G Maartens South African Medical Journal 104 (2), 104-106, 2014 | 42 | 2014 |
| The prevalence of noma in northwest Nigeria E Farley, MJ Oyemakinde, J Schuurmans, C Ariti, F Saleh, G Uzoigwe, ... BMJ global health 5 (4), 2020 | 40 | 2020 |
| Pharmacovigilance: the devastating consequences of not thinking about adverse drug reactions: The burden of adverse drug reactions (ADRs) on patient care has been found to be … UC Mehta Continuing medical education 29 (6), 2011 | 38 | 2011 |
| ‘I treat it but I don’t know what this disease is’: a qualitative study on noma (cancrum oris) and traditional healing in northwest Nigeria E Farley, HM Bala, A Lenglet, U Mehta, N Abubakar, J Samuel, A de Jong, ... International health 12 (1), 28-35, 2020 | 31 | 2020 |
| Safety and effectiveness of isoniazid preventive therapy in pregnant women living with human immunodeficiency virus on antiretroviral therapy: an observational study using … E Kalk, A Heekes, U Mehta, R de Waal, N Jacob, K Cohen, L Myer, ... Clinical Infectious Diseases 71 (8), e351-e358, 2020 | 29 | 2020 |
